Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wayne Tam

Showing results (101-110 of 140) with videos related to

Pageof 14
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 15, 2021
Myeloid/lymphoid neoplasms with FLT3 rearrangementGuilin Tang, Wayne Tam, Nicholas J Short, et al.
Medrxiv : the Preprint Server for Health Sciences|September 16, 2020
Longitudinal immune profiling of mild and severe COVID-19 reveals innate and adaptive immune dysfunction and provides an early prediction tool for clinical progressionAndré F Rendeiro, Joseph Casano, Charles Kyriakos Vorkas, et al.
Blood|October 24, 2012
Targeted genomic sequencing of pediatric Burkitt lymphoma identifies recurrent alterations in antiapoptotic and chromatin-remodeling genesLisa Giulino-Roth, Kai Wang, Theresa Y MacDonald, et al.
Blood Advances|November 25, 2025
MRD-driven Initial Therapy of Acalabrutinib and Lenalidomide plus Rituximab (ALR) or Obinutuzumab (ALO) for Mantle Cell LymphomaJia Ruan, David A Bond, Bijal D Shah, et al.
Cancer Discovery|February 25, 2017
BCL6 Antagonizes NOTCH2 to Maintain Survival of Human Follicular Lymphoma CellsEster Valls, Camille Lobry, Huimin Geng, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2023
Triple-Negative Primary Myelofibrosis: A Bone Marrow Pathology Group StudyYahya A Al-Ghamdi, Jonathan Lake, Adam Bagg, et al.
The Journal of Clinical Investigation|August 3, 2016
Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphomaMariano G Cardenas, Wenbo Yu, Wendy Beguelin, et al.
Nature|July 5, 2019
Somatic mutations and cell identity linked by Genotyping of TranscriptomesAnna S Nam, Kyu-Tae Kim, Ronan Chaligne, et al.
Human Pathology|June 19, 2026
Evaluation of Prognostic Factors and Outcomes in Primary versus Secondary Myeloid SarcomaChristine W Kahlow, Sharon Germans, Maximiliano Ramia de Cap, et al.
The American Journal of Pathology|June 20, 2017
AKT Hyperactivation and the Potential of AKT-Targeted Therapy in Diffuse Large B-Cell LymphomaJinfen Wang, Zijun Y Xu-Monette, Kausar J Jabbar, et al.
Pageof 14

Showing results (101-110 of 140) with videos related to

Sort By:
Pageof 14
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 15, 2021
Myeloid/lymphoid neoplasms with FLT3 rearrangementGuilin Tang, Wayne Tam, Nicholas J Short, et al.
Medrxiv : the Preprint Server for Health Sciences|September 16, 2020
Longitudinal immune profiling of mild and severe COVID-19 reveals innate and adaptive immune dysfunction and provides an early prediction tool for clinical progressionAndré F Rendeiro, Joseph Casano, Charles Kyriakos Vorkas, et al.
Blood|October 24, 2012
Targeted genomic sequencing of pediatric Burkitt lymphoma identifies recurrent alterations in antiapoptotic and chromatin-remodeling genesLisa Giulino-Roth, Kai Wang, Theresa Y MacDonald, et al.
Blood Advances|November 25, 2025
MRD-driven Initial Therapy of Acalabrutinib and Lenalidomide plus Rituximab (ALR) or Obinutuzumab (ALO) for Mantle Cell LymphomaJia Ruan, David A Bond, Bijal D Shah, et al.
Cancer Discovery|February 25, 2017
BCL6 Antagonizes NOTCH2 to Maintain Survival of Human Follicular Lymphoma CellsEster Valls, Camille Lobry, Huimin Geng, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2023
Triple-Negative Primary Myelofibrosis: A Bone Marrow Pathology Group StudyYahya A Al-Ghamdi, Jonathan Lake, Adam Bagg, et al.
The Journal of Clinical Investigation|August 3, 2016
Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphomaMariano G Cardenas, Wenbo Yu, Wendy Beguelin, et al.
Nature|July 5, 2019
Somatic mutations and cell identity linked by Genotyping of TranscriptomesAnna S Nam, Kyu-Tae Kim, Ronan Chaligne, et al.
Human Pathology|June 19, 2026
Evaluation of Prognostic Factors and Outcomes in Primary versus Secondary Myeloid SarcomaChristine W Kahlow, Sharon Germans, Maximiliano Ramia de Cap, et al.
The American Journal of Pathology|June 20, 2017
AKT Hyperactivation and the Potential of AKT-Targeted Therapy in Diffuse Large B-Cell LymphomaJinfen Wang, Zijun Y Xu-Monette, Kausar J Jabbar, et al.
Pageof 14